HTGC : Summary for Hercules Capital, Inc. Common S - Yahoo Finance

U.S. Markets close in 5 hrs 19 mins

Hercules Capital, Inc. (HTGC)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
15.22+0.05 (+0.30%)
As of 10:40AM EST. Market open.
People also watch
TCAPARCCPNNTTICCBKCC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close15.17
Open15.23
Bid0.00 x
Ask0.00 x
Day's Range15.18 - 15.33
52 Week Range9.95 - 15.33
Volume152,416
Avg. Volume437,462
Market Cap1.17B
Beta0.96
PE Ratio (TTM)16.36
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.24 (8.17%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire18 days ago

    Axovant Sciences Announces $55.0 Million Venture Debt Financing from Hercules Capital

    BASEL, Switzerland, Feb. 3, 2017 /PRNewswire/ -- Axovant Sciences (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced that it has entered into a $55.0 million debt financing agreement with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"), a leader in customized debt financing for companies in life sciences and technology-related markets. "This financing provides Axovant additional flexibility to pursue its mission of developing comprehensive solutions for patients with dementia," stated Vivek Ramaswamy, Chief Executive Officer of Axovant Sciences.

  • Business Wire19 days ago

    Hercules Announces Date for Release of Fourth Quarter and Full-Year 2016 Financial Results and Conference Call

    Hercules Capital, Inc. , the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has scheduled its fourth quarter and full-year 2016 financial results conference call for Thursday, February 23, 2017, at 2:00 p.m.

  • Business Wire20 days ago

    Hercules Announces Upcoming Event for Financial Community

    Hercules Capital, Inc. , the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that Manuel A.